California Congresswoman Nancy Pelosi and her husband Paul have profited significantly from strategic stock investments, most recently doubling their money in Tempus AI after buying shares shortly before a substantial acquisition. This timely investment comes amidst a cautious atmosphere for AI companies, marked by several notable failures in the medical AI sector. The couple's financial acumen has not gone unnoticed, with a dedicated social media account celebrating their successful stock maneuvers.
"Pelosi really is the GOAT," the post read. "Back on [January 14], she bought ~100K of Tempus AI... She doubled her money in just three weeks."
The value pump started almost immediately after Pelosi's buy, and continued after Tempus acquired Ambry Genetics, a genetic testing lab firm valued at over $300 million.
Collection
[
|
...
]